CLINICAL_TRIALS
trial_result
· 2017-02-20
Clinical Trial Update: CC-5013 With or Without Dexamethasone in Treating Patients With Primary Systemic Amyloidosis [Phase 2]
Summary
Phase 2 trial evaluating lenalidomide (CC-5013) with or without dexamethasone for AL amyloidosis; results were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vaishali Sanchorawala | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2017-02-20